• 146,271+ Medical Conferences
  • 284 Specialties
  • 10,910 Organizers
  • 154,716 Speakers
  • 156 Countries
  • 4,682 Cities
CME Conference Registrations Sold
Home  >  Conferences  >  4th Annual Gene Therapy for Rare Disorders

4th Annual Gene Therapy for Rare Disorders

Mar 30 - Apr 02, 2020   |   Boston, Massachusetts  United States Of America
Organized by : Hanson Wade
Specialties : Genetics   |   Biotechnology
  Register Now
Conference Brochure

4th Annual Gene Therapy for Rare Disorders is organized by Hanson Wade and will be held from Mar 30 - Apr 02, 2020 at Boston Park Plaza, Boston, Massachusetts, United States of America.

Gene therapies are redefining the treatment of rare diseases. However, a set of complex and unique challenges must be overcome for these therapeutics to achieve their commercial potential.

With larger populations and higher doses required, manufacturing issues are more prominent than ever. That’s why the 2020 agenda will devote two tracks solely to overcoming manufacturing issues, enabling you to:
• Meet regulatory expectations for CMC and analytical packages
• Implement robust and scalable manufacturing processes
• Handle the rapidly evolving logistical and infrastructure challenges facing the space

More gene therapies are in the clinic than ever before. In the context of this unprecedented progress, the event will give significant attention to clinical issues including:
• Maximizing meaningful output from trials through creative clinical trial design
• Incorporating the patient voice into clinical development
• Navigating the realities of the global regulatory landscape in light of recent approvals

How do you price gene therapies? This question and issues around reimbursement, payment models and the commercial realities of the space will form the basis of the commercial track, with insights that will enable you to:
• Understand the payer perspective on balancing access and affordability
• Contrast a variety of payment models including outcome- and performance-based payments
• Evaluating the commercial realities of rare and ultra-rare disease business models

Key Benefits of Attending:
Implement Effective Analytical & CMC Approaches to Improve Safety, Potency & Purity 

Explore technical insights into the analytical approaches supporting Spark Therapeutics’ gene therapy development and understand how bluebird bio have aligned CMC with regulatory expectations to support an approval

Establish Robust & Scalable Manufacturing Processes & Infrastructure to Support Increasing Demand
Equip yourself for commercial manufacturing, however you utilize capacity – from making initial ‘make vs buy’ decisions, to CMO management and facility design, validation and maintenance, with insights from Pfizer, BioMarin and Sanofi

Navigate the Complex Global Gene Therapy Regulatory Environment
Learn directly from international regulatory bodies including the FDA and China’s CFDA, to understand the realities of global regulatory expectations and how regulatory oversight is adapting to technical innovations in the field

Examine Innovative Financing & Reimbursement Strategies
Understand the payer perspective on the reimbursement strategies that are available, which approaches are working, which are not and how future government action will impact pricing and value-based agreements, with insights from Harvard Pilgrim Health, Blue Cross Blue Shield of Massachusetts and ICER

Investigate Novel Vectors to Enhance Selectivity & Efficacy While Reducing Immunogenicity Look beyond the current crop of gene therapy vectors to gain an insight into the next generation of delivery technologies with the promise to dramatically enhance the specificity of targeting, reduce costs of manufacturing and overcome immunogenicity challenges, with insights from 4D Molecular Therapeutics and Duke University School of Medicine

Main Conference - March 31
Pre-Conference Workshops - Monday, March 30

Morning Workshops
Workshop A:  9:00am - 12:00pm
Workshop B: 9:00am - 12:00pm
Workshop C: 9:00am - 12:00pm
Workshop D: 9:00am - 12:00pm

Afternoon Workshops
Workshop E: 1:00pm - 4:00pm
Workshop F: 1:00pm - 4:00pm
Workshop G: 1:00pm - 4:00pm
Workshop H: 1:00pm - 4:00pm

Additional details will be posted as soon as information is available.

View All Speaking

Christopher Tipper
Christopher Tipper

Molecular Biology

Lance Weed
Lance Weed

Healthcare Technology

Bryan A. Piras
Bryan A. Piras


Federico Mingozzi
Federico Mingozzi

Biochemistry and Molecular Genetics

Registration Desk

Contact No. : 16174554188


Registration Type Last Date Price
Drug Developer Pricing: 2 Day Conference Plus Workshop Day AND Discussion Day - Conference Fee 29 Mar,2020 USD 5395.00
Drug Developer Pricing: 2 Day Conference Plus Workshop Day OR Discussion Day - Conference Fee 29 Mar,2020 USD 4197.00
Drug Developer Pricing: 2 Day Conference - Conference Fee 29 Mar,2020 USD 2999.00
Standard Pricing: 2 Day Conference Plus Workshop Day AND Discussion Day - Conference Fee 29 Mar,2020 USD 6395.00
Standard Pricing: 2 Day Conference Plus Workshop Day OR Discussion Day - Conference Fee 29 Mar,2020 USD 5197.00
Standard Pricing: 2 Day Conference - Conference Fee 29 Mar,2020 USD 3999.00
View Expired Tickets
view all
  • Drive Walk Transit Bicycle

Venue Address

Boston Park Plaza
50 Park Plaza
Boston, Massachusetts, United States Of America

Plan Your Travel


Please Rate this Conference


Reviews Given by People

No Reviews available. Be the first to write a review.

Hotels Near Venue

Freepoint Hotel Cambridge, Tapestry Collection by Hilton
4.54 miles from venue
Price : USD 259.00 Per Night
The Charles Hotel in Harvard Square
3.04 miles from venue
Price : USD 649.00 Per Night
Encore Boston Harbor
3.03 miles from venue
, Free Wifi
Price : USD 0.00 Per Night
The Row Hotel at Assembly Row, Autograph Collection by Marriott
2.97 miles from venue
Price : USD 159.00 Per Night

Session Details

Session Topic Start Time End Time Location Speakers

Workshop Details

Title Start Time End Time Workshop Fee

Subscribe to our Newsletter


Subscribe to our newsletter and receive updates on medical conferences, board review courses and news